The North West Centre for Advanced Manufacturing (NWCAM) is a new trans-regional centre for the research and development of innovative solutions and is funded by the EU’s INTERREG VA Programmes for €8.7m which is managed by the SEUPB.
Catalyst is the lead partner in the delivery of the project.NWCAM links the academic capabilities of Northern Ireland, Republic of Ireland and West coast of Scotland to develop and deliver, in partnership with industry partners, 16 world leading research projects within the Life and Health Science sector. The collaborative research projects have the potential to deliver global products and processes that can be licensed throughout the world.
The 16 individual Research & Innovation projects span the following Advanced Manufacturing areas:
The projects are led by investigators who are world leaders in their respective fields and delivered by 13 post-doctoral researchers and 13 PhD students that are creating innovative solutions for the challenges faced by the industrial partners. The students will dedicate their course of study to these problems and will be intensively trained to become our innovators of tomorrow.
We are proud to celebrate the success and career progression of our NWCAM researchers.
Find out more about the NWCAM Alumni here.
Hear from the NWCAM team and Industry Partners
2020 - Year in review
Find out more about the conference here.
Interim Director of Finance & Administration
John Carew is the Interim Director of Finance & Administration at Catalyst, responsible for management of project finances, IT and the overall governance function.
Before joining Catalyst in May 2015, John gained experience in a variety of financial roles in both public and private organisations, having qualified as an accountant in 2010. He also held a part-time lecturing role up to 2020, teaching CIMA and ACCA students for over nine years.
Prior to his career change in 2006, John spent over ten years working as a research scientist, with roles in Northern Ireland and GB, including seven years with a Cambridge biotech start-up, focussed on the identification of novel cancer treatments, which was acquired by AstraZeneca.
John holds a BSc(Hons) in Biochemical Sciences and is a Fellow of the Chartered Institute of Management Accountants.
Stay up to date with news, events and more.
We Are Catalyst - © 2023
